NCT04674332View on ClinicalTrials.gov

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Long Acting Insulin in Control of Gestational Diabetes Mellitus
Interventions
DRUG

Long acting insulin

long acting insulin analogue once daily at bed time

DRUG

multiple dose regimen

intermediate and short acting insulin

Trial Locations (1)

Unknown

Ain Shams University Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04674332 - Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter